menu
    • menu

    Company profile for Spruce Biosciences

    NEW Drugs in Dev: 3
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Spruce Biosciences is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders. Our team has extensive expertise in endocrinology and orphan drug development and our lead product candidate, Tildacerfont (SPR001), has the potential to be the first FDA-approved therapy for congenital adrenal hyperplasia (CAH), a rare endocrine disease. We are headquartered in San Francisco and have raised a ...
    Spruce Biosciences is a clinical-stage biotechnology company developing novel therapies for rare endocrine disorders. Our team has extensive expertise in endocrinology and orphan drug development and our lead product candidate, Tildacerfont (SPR001), has the potential to be the first FDA-approved therapy for congenital adrenal hyperplasia (CAH), a rare endocrine disease. We are headquartered in San Francisco and have raised a total of $28M. Or lead program, SPR001, is currently in Phase 2 clinical trials for CAH. For more information on CAH please visit our patient resources section.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Spruce BiosciencesUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1700 Montgomery St Suite 212 San Francisco, CA 94111
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://sprucebiosciences.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Spruce Bio Presents Data At 22nd Worldsymposium 2026
    Spruce Bio Presents Data At 22nd Worldsymposium 2026

    28 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260128573673/en/Spruce-Biosciences-Announces-Data-Presentations-at-the-22nd-Annual-WORLDSymposium

    BUSINESSWIRE
    28 Jan 2026
    Share Share
    Harbour Biomed Acquires Common Stock In Spruce Biosciences
    Harbour Biomed Acquires Common Stock In Spruce Biosciences

    18 Jan 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/harbour-biomed-acquires-common-stock-in-spruce-biosciences-deepening-strategic-collaboration-302664109.html

    PR NEWSWIRE
    18 Jan 2026
    Share Share
    Spruce Bio Secures $50M Growth Capital From Avenue Capital
    Spruce Bio Secures $50M Growth Capital From Avenue Capital

    08 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260108628049/en/Spruce-Biosciences-Secures-Up-to-%2450-Million-in-Growth-Capital-from-Avenue-Capital

    BUSINESSWIRE
    08 Jan 2026
    Share Share
    Spruce Bio Appoints Keli Walbert To Board of Directors
    Spruce Bio Appoints Keli Walbert To Board of Directors

    15 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251215189566/en/Spruce-Biosciences-Appoints-Proven-Pharmaceutical-Commercial-Leader-Keli-Walbert-to-Board-of-Directors

    BUSINESSWIRE
    15 Dec 2025
    Share Share
    Spruce Bio Reveals Q3 2025 Financials And Corporate Updates
    Spruce Bio Reveals Q3 2025 Financials And Corporate Updates

    10 Nov 2025

    // BUSINESS WIRE

    https://www.businesswire.com/news/home/20251110552861/en/Spruce-Biosciences-Reports-Third-Quarter-2025-Financial-Results-and-Provides-Corporate-Updates

    BUSINESS WIRE
    10 Nov 2025
    Share Share
    Spruce Bio Announces $50M Private Placement Financing
    Spruce Bio Announces $50M Private Placement Financing

    08 Oct 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251008435141/en/Spruce-Biosciences-Announces-%2450.0-Million-Private-Placement-Financing

    BUSINESSWIRE
    08 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search